y 27632 has been researched along with irl 1620 in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (irl 1620) | Trials (irl 1620) | Recent Studies (post-2010) (irl 1620) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 257 | 2 | 27 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Assaloni, R; Bartoli, E; Cavarape, A; Endlich, K; Endlich, N; Parekh, N; Steinhausen, M | 1 |
1 other study(ies) available for y 27632 and irl 1620
Article | Year |
---|---|
Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo.
Topics: Adenosine; Amides; Animals; Endothelins; Enzyme Inhibitors; Female; Guanylate Cyclase; Indoles; Intracellular Signaling Peptides and Proteins; Oxadiazoles; Peptide Fragments; Protein Kinase C; Protein Serine-Threonine Kinases; Purinergic P1 Receptor Agonists; Pyridines; Quinoxalines; Rats; Rats, Wistar; Receptor, Endothelin B; Receptors, Endothelin; Renal Circulation; rho-Associated Kinases; Signal Transduction; Vasoconstriction; Vasomotor System | 2003 |